Back

Impact of PAH-specific vasodilator therapy on long-term survival in eisenmenger syndrome: a prospective cohort study

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Adult congenital heart disease: risk factors and clinical outcomes Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ananya Diwan

Chennai (India)

7 More presentations in this session

Presentation thumbnail
Clinical outcomes of adults with anomalous aortic origin of a coronary artery: 2-year data from the multicenter study on coronary anomalies in The Netherlands (MuSCAT)
Mr W. Saleh (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Primary amenorrhea is common after fontan circulation and independently predicted by elevated adolescent BNP
Doctor K. Matsuo (Izumi City,Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Myopenia and exercise capacity in adult fontan patients: the association between appendicular lean mass and cardiopulmonary performance
Doctor A. Wittczak (Lodz, PL)
Abstract Slides Video
Presentation thumbnail
Evaluation of Fontan-associated liver disease by a novel predictive index. Data from the prospective Fontan cohort monitored in a liver centre
Doctor L. Cavalletto (Padova, IT)
Abstract Slides Video
Presentation thumbnail
Lifelong non-cardiac comorbidity burden and mortality risk in adults with lower-complex congenital heart disease: a population-based cohort study from the UK Biobank
Doctor J. Zhang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Adult congenital heart disease: risk factors and clinical outcomes

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Evaluating the safety and long-term efficacy of triple vasodilator therapy for pulmonary arterial hypertension associated with congenital heart disease
27 August 2023
thumbnail
Congress Presentation
Long-term survival outcomes and baseline hemodynamics in patients with PAH versus CTEPH
12 May 2024
thumbnail
Congress Presentation
Metoprolol therapy in patients with Eisenmenger syndrome (MINES) study. A single-centre, double-blinded, randomised, placebo-controlled trial
2 September 2024
thumbnail
Congress Presentation
Pulmonary hypertension after mitral valve surgery
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources